1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Digestive Remedies in Spain

Digestive Remedies in Spain

  • September 2016
  • -
  • Euromonitor International
  • -
  • 28 pages

In 2016, consumers are becoming increasingly confident about self-medicating with digestive remedies. The better economic situation along with the fact that consumers are becoming increasingly informed about OTC products are key factors that explain the increased willingness of Spaniards to self-medicate. Digestive remedies has grown by 2% in 2016.

Euromonitor International’s Digestive Remedies in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Digestive Remedies in Spain
DIGESTIVE REMEDIES IN SPAIN
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2011-2016
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Digestive Remedies: % Value 2012-2016
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2013-2016
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2016-2021
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Almirall SA in Consumer Health (spain)
Strategic Direction
Key Facts
Summary 1 Almirall SA: Key Facts
Summary 2 Almirall SA: Operational Indicators
Competitive Positioning
Summary 3 Almirall SA: Competitive Position 2016
Arkopharma SA in Consumer Health (spain)
Strategic Direction
Key Facts
Summary 4 Arkopharma SA: Key Facts
Competitive Positioning
Summary 5 Arkopharma SA: Competitive Position 2016
Bayer Hispania SA in Consumer Health (spain)
Strategic Direction
Key Facts
Summary 6 Bayer Hispania SL: Key Facts
Summary 7 Bayer Hispania SL: Operational Indicators
Competitive Positioning
Summary 8 Bayer Hispania SA: Competitive Position 2016
Esteve SA in Consumer Health (spain)
Strategic Direction
Key Facts
Summary 9 Esteve SA: Key Facts
Summary 10 Esteve SA: Operational Indicators
Competitive Positioning
Summary 11 Esteve SA: Competitive Position 2016
Executive Summary
Economic Recovery Helps
in Search of Healthy Lifestyles
No Surprises in the Spanish Competitive Landscape
Online Sales Did Not Surprise the Industry
Outlook More Positive
Key Trends and Developments
Economic Recovery Supports Sales
Overweight Spaniards Want To Look Thin and Be Healthy
Herbal Ingredients Gaining Ground
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 8 Life Expectancy at Birth 2011-2016
Market Data
Table 9 Sales of Consumer Health by Category: Value 2011-2016
Table 10 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 11 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 12 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 12 OTC: Switches 2014-2016
Definitions
Sources
Summary 13 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Gastroesophageal Reflux Disease (GERD)  - Market Insights, Epidemiology and Market Forecast-2023

Gastroesophageal Reflux Disease (GERD)  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Gastroesophageal Reflux Disease (GERD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Gastroesophageal ...

Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023

Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro-Kinetic Agents), By Region, And Segment Forecasts, 2014 - 2025

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro-Kinetic Agents), By Region, And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • February 2017
  • by Grand View Research

The global Gastroesophageal Reflux Disease (GERD) therapeutics market is expected to reach USD 4.34 billion by 2025, according to a new study by Grand View Research, Inc. The incidence of acid reflux disorder, ...


Download Unlimited Documents from Trusted Public Sources

Gastrointestinal Drug Industry in Canada

  • March 2017
    92 pages
  • Gastrointestina...  

    Health Care Pro...  

    Ambulatory Care  

  • Canada  

    North America  

View report >

Gastrointestinal Drug Industry in the US - Forecast

  • January 2017
    4 pages
  • Gastrointestina...  

    Digestive Syste...  

    Hormone  

  • United States  

View report >

Gastrointestinal Drug Industry in the US

  • January 2017
    8 pages
  • Gastrointestina...  

    Digestive Syste...  

  • United States  

View report >

Related Market Segments :

Gastrointestinal Drug

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.